Cheaper isn’t always better, and prescription drugs are no exception

The government's move toward a fair-equals-cheap model of drug pricing may have long-term implications for patients and our health-care system.

The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade

Opinion

BY JASON FIELD

December 15, 2017

Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent. Taking a page from United States President Donald Trump, Prime Minister Justin Trudeau's government has adopted a reductive, fair-means-cheap pricing equation...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy